{"nctId":"NCT03479307","briefTitle":"A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.","startDateStruct":{"date":"2018-04-07","type":"ACTUAL"},"conditions":["Allergic Conjunctivitis"],"count":228,"armGroups":[{"label":"Bilastine Ophthalmic Solution 0.6%","type":"EXPERIMENTAL","interventionNames":["Drug: Bilastine Ophthalmic Solution 0.6%"]},{"label":"Ketotifen Ophthalmic Solution 0.025% (Zaditen)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ketotifen Ophthalmic Solution 0.025% (Zaditen)"]},{"label":"Vehicle of Bilastine Ophthalmic Solution","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Vehicle of Bilastine Ophthalmic Solution"]}],"interventions":[{"name":"Bilastine Ophthalmic Solution 0.6%","otherNames":[]},{"name":"Ketotifen Ophthalmic Solution 0.025% (Zaditen)","otherNames":["Zaditen"]},{"name":"Vehicle of Bilastine Ophthalmic Solution","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* be at least 18 years old\n* be willing and able to avoid all disallowed medications and contact lenses\n* must have a pregnancy test if of childbearing potential\n* must be able to read an eye chart from 10 feet away\n\nExclusion Criteria:\n\n* must not have any allergies to the study medications\n* must not have any ocular or non ocular condition that investigator feels will interfere with study parameters\n* must not have used immunotherapy in the last 2 years\n* must not have used an investigational drug or device in the past 30 days or concurrently enrolled in another investigational trial","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ocular Itching","description":"The primary efficacy measure was ocular itching evaluated by the subject at 3 (± 1), 5 (±1), and 7 (± 1) minutes post-CAC (Conjunctival Allergen Challenge) at Visits 4b and 5, using a 0 to 4 Ora Calibra scale (0 = None , 4= An incapacitating itch with an irresistible urge to rub).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.609","spread":"0.9013"},{"groupId":"OG001","value":"1.886","spread":"0.9504"},{"groupId":"OG002","value":"2.219","spread":"0.9644"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.750","spread":"0.9508"},{"groupId":"OG001","value":"1.919","spread":"0.9670"},{"groupId":"OG002","value":"2.490","spread":"0.8996"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.747","spread":"1.0283"},{"groupId":"OG001","value":"1.894","spread":"0.9606"},{"groupId":"OG002","value":"2.526","spread":"0.9035"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.669","spread":"0.7926"},{"groupId":"OG001","value":"0.658","spread":"0.6745"},{"groupId":"OG002","value":"1.840","spread":"0.9258"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.828","spread":"0.8879"},{"groupId":"OG001","value":"0.902","spread":"0.8208"},{"groupId":"OG002","value":"2.011","spread":"0.9058"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.826","spread":"0.8901"},{"groupId":"OG001","value":"0.981","spread":"0.9224"},{"groupId":"OG002","value":"1.931","spread":"0.8703"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":91},"commonTop":["Visual Acuty Reduced","Conjunctivitis","Hordeolum","Sinusitis","Tooth Abscess"]}}}